o2h ventures has so far invested in 25 promising early stage biotech companies in the UK from the Human Health EIS fund as well as angel investments.
our full portfolio
A-Z Z-A Default
Active Exited All
Anti-ageing Anti-infectives Auto Immune & Inflamation Cardiovascular Multi Therapautics Neurosciences Ocular Oncology All
Fund Investment Pre-Fund Investment All
Sorry, no results found with this search